<VariationArchive RecordType="classified" VariationID="977923" VariationName="NM_001165963.4(SCN1A):c.1133del (p.Leu378fs)" VariationType="Deletion" Accession="VCV000977923" Version="6" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2023-08-06" DateCreated="2020-09-18" MostRecentSubmission="2021-07-07">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="966052" VariationID="977923">
      <GeneList>
        <Gene Symbol="SCN1A" FullName="sodium voltage-gated channel alpha subunit 1" GeneID="6323" HGNC_ID="HGNC:10585" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="165984641" stop="166149161" display_start="165984641" display_stop="166149161" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="166845669" stop="167005641" display_start="166845669" display_stop="167005641" Strand="-" />
          </Location>
          <OMIM>182389</OMIM>
          <Haploinsufficiency last_evaluated="2012-07-06" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SCN1A">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2012-07-06" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SCN1A">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001165963.4(SCN1A):c.1133del (p.Leu378fs)</Name>
      <CanonicalSPDI>NC_000002.12:166047663:A:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>2q24.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="166047664" stop="166047664" display_start="166047664" display_stop="166047664" variantLength="1" positionVCF="166047663" referenceAlleleVCF="TA" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="166904174" stop="166904174" display_start="166904174" display_stop="166904174" variantLength="1" positionVCF="166904173" referenceAlleleVCF="TA" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>L378fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.166904174del" Assembly="GRCh37">
            <Expression>NC_000002.11:g.166904174del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.166047664del" Assembly="GRCh38">
            <Expression>NC_000002.12:g.166047664del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011906.1" sequenceAccession="NG_011906" sequenceVersion="1" change="g.30976del">
            <Expression>NG_011906.1:g.30976del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001165963.4" sequenceAccession="NM_001165963" sequenceVersion="4" change="c.1133del" MANESelect="true">
            <Expression>NM_001165963.4:c.1133del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001159435.1" sequenceAccession="NP_001159435" sequenceVersion="1" change="p.Leu378fs">
            <Expression>NP_001159435.1:p.Leu378fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001165964.3" sequenceAccession="NM_001165964" sequenceVersion="3" change="c.1133del">
            <Expression>NM_001165964.3:c.1133del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001159436.1" sequenceAccession="NP_001159436" sequenceVersion="1" change="p.Leu378fs">
            <Expression>NP_001159436.1:p.Leu378fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001202435.3" sequenceAccession="NM_001202435" sequenceVersion="3" change="c.1133del">
            <Expression>NM_001202435.3:c.1133del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001189364.1" sequenceAccession="NP_001189364" sequenceVersion="1" change="p.Leu378fs">
            <Expression>NP_001189364.1:p.Leu378fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001353948.2" sequenceAccession="NM_001353948" sequenceVersion="2" change="c.1133del">
            <Expression>NM_001353948.2:c.1133del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001340877.1" sequenceAccession="NP_001340877" sequenceVersion="1" change="p.Leu378fs">
            <Expression>NP_001340877.1:p.Leu378fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001353949.2" sequenceAccession="NM_001353949" sequenceVersion="2" change="c.1133del">
            <Expression>NM_001353949.2:c.1133del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001340878.1" sequenceAccession="NP_001340878" sequenceVersion="1" change="p.Leu378fs">
            <Expression>NP_001340878.1:p.Leu378fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001353950.2" sequenceAccession="NM_001353950" sequenceVersion="2" change="c.1133del">
            <Expression>NM_001353950.2:c.1133del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001340879.1" sequenceAccession="NP_001340879" sequenceVersion="1" change="p.Leu378fs">
            <Expression>NP_001340879.1:p.Leu378fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001353951.2" sequenceAccession="NM_001353951" sequenceVersion="2" change="c.1133del">
            <Expression>NM_001353951.2:c.1133del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001340880.1" sequenceAccession="NP_001340880" sequenceVersion="1" change="p.Leu378fs">
            <Expression>NP_001340880.1:p.Leu378fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001353952.2" sequenceAccession="NM_001353952" sequenceVersion="2" change="c.1133del">
            <Expression>NM_001353952.2:c.1133del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001340881.1" sequenceAccession="NP_001340881" sequenceVersion="1" change="p.Leu378fs">
            <Expression>NP_001340881.1:p.Leu378fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001353954.2" sequenceAccession="NM_001353954" sequenceVersion="2" change="c.1133del">
            <Expression>NM_001353954.2:c.1133del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001340883.1" sequenceAccession="NP_001340883" sequenceVersion="1" change="p.Leu378fs">
            <Expression>NP_001340883.1:p.Leu378fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001353955.2" sequenceAccession="NM_001353955" sequenceVersion="2" change="c.1133del">
            <Expression>NM_001353955.2:c.1133del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001340884.1" sequenceAccession="NP_001340884" sequenceVersion="1" change="p.Leu378fs">
            <Expression>NP_001340884.1:p.Leu378fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001353957.2" sequenceAccession="NM_001353957" sequenceVersion="2" change="c.1133del">
            <Expression>NM_001353957.2:c.1133del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001340886.1" sequenceAccession="NP_001340886" sequenceVersion="1" change="p.Leu378fs">
            <Expression>NP_001340886.1:p.Leu378fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001353958.2" sequenceAccession="NM_001353958" sequenceVersion="2" change="c.1133del">
            <Expression>NM_001353958.2:c.1133del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001340887.1" sequenceAccession="NP_001340887" sequenceVersion="1" change="p.Leu378fs">
            <Expression>NP_001340887.1:p.Leu378fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001353960.2" sequenceAccession="NM_001353960" sequenceVersion="2" change="c.1133del">
            <Expression>NM_001353960.2:c.1133del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001340889.1" sequenceAccession="NP_001340889" sequenceVersion="1" change="p.Leu378fs">
            <Expression>NP_001340889.1:p.Leu378fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001353961.2" sequenceAccession="NM_001353961" sequenceVersion="2" change="c.-1293del">
            <Expression>NM_001353961.2:c.-1293del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006920.6" sequenceAccession="NM_006920" sequenceVersion="6" change="c.1133del">
            <Expression>NM_006920.6:c.1133del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_008851.3" sequenceAccession="NP_008851" sequenceVersion="3" change="p.Leu378fs">
            <Expression>NP_008851.3:p.Leu378fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_148667.2" sequenceAccession="NR_148667" sequenceVersion="2" change="n.1519del">
            <Expression>NR_148667.2:n.1519del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_8" sequenceAccession="LRG_8">
            <Expression>LRG_8:g.30976del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006920.6" sequenceAccession="NM_006920" sequenceVersion="6" change="c.1133delT">
            <Expression>NM_006920.6:c.1133delT</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001165963.4" sequenceAccession="NM_001165963" sequenceVersion="4" change="c.1133delT" MANESelect="true">
            <Expression>NM_001165963.4:c.1133delT</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1698004184" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001165963.4(SCN1A):c.1133del (p.Leu378fs) AND multiple conditions" Accession="RCV001255853" Version="4">
        <ClassifiedConditionList TraitSetID="9626">
          <ClassifiedCondition DB="MedGen" ID="C1858673">Generalized epilepsy with febrile seizures plus, type 2</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0751122">Severe myoclonic epilepsy in infancy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-06-11" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001165963.4(SCN1A):c.1133del (p.Leu378fs) AND Severe myoclonic epilepsy in infancy" Accession="RCV001528186" Version="2">
        <ClassifiedConditionList TraitSetID="1766">
          <ClassifiedCondition DB="MedGen" ID="C0751122">Severe myoclonic epilepsy in infancy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2020-06-11" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2020-09-18" MostRecentSubmission="2021-07-07">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <DescriptionHistory Dated="2021-07-02">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9626" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9389" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Generalized epilepsy with febrile seizures plus, type 2</ElementValue>
                <XRef ID="Generalized+epilepsy+with+febrile+seizures+plus%2C+type+2/8460" DB="Genetic Alliance" />
                <XRef ID="MONDO:0011461" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GEFS+, TYPE 2</ElementValue>
                <XRef Type="MIM" ID="604403" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">GEFSP2</ElementValue>
                <XRef Type="MIM" ID="604403" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">GEFS+2</ElementValue>
                <XRef Type="MIM" ID="604403" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">SCN1A-Related Seizure Disorders</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">SCN1A seizure disorders encompass a spectrum that ranges from simple febrile seizures and generalized epilepsy with febrile seizures plus (GEFS+) at the mild end to Dravet syndrome and intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC) at the severe end. Phenotypes with intractable seizures including Dravet syndrome are often associated with cognitive decline. Less commonly observed phenotypes include myoclonic astatic epilepsy (MAE), Lennox-Gastaut syndrome, infantile spasms, epilepsy with focal seizures, and vaccine-related encephalopathy and seizures. The phenotype of SCN1A seizure disorders can vary even within the same family.</Attribute>
                <XRef ID="NBK1318" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301494</ID>
                <ID Source="BookShelf">NBK1318</ID>
              </Citation>
              <XRef ID="36387" DB="Orphanet" />
              <XRef ID="C1858673" DB="MedGen" />
              <XRef ID="MONDO:0011461" DB="MONDO" />
              <XRef Type="MIM" ID="604403" DB="OMIM" />
            </Trait>
            <Trait ID="4140" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Dravet syndrome</ElementValue>
                <XRef ID="MONDO:0100135" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Severe myoclonic epilepsy in infancy</ElementValue>
                <XRef ID="219513" DB="GeneTests" />
                <XRef ID="Dravet+Syndrome/2332" DB="Genetic Alliance" />
                <XRef ID="230437002" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Epileptic encephalopathy, early infantile, 6 (Dravet syndrome)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 6A</ElementValue>
                <XRef Type="MIM" ID="607208" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Epilepsy, Myoclonic, Infantile, Severe</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">ICE-GTC</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">DRVT</ElementValue>
                <XRef Type="MIM" ID="607208" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">SMEI</ElementValue>
                <XRef Type="MIM" ID="607208" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">SME</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">DEE6A</ElementValue>
                <XRef Type="MIM" ID="607208" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">EIEE6</ElementValue>
                <XRef Type="MIM" ID="607208" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">SCN1A seizure disorders encompass a spectrum that ranges from simple febrile seizures and generalized epilepsy with febrile seizures plus (GEFS+) at the mild end to Dravet syndrome and intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC) at the severe end. Phenotypes with intractable seizures including Dravet syndrome are often associated with cognitive decline. Less commonly observed phenotypes include myoclonic astatic epilepsy (MAE), Lennox-Gastaut syndrome, infantile spasms, epilepsy with focal seizures, and vaccine-related encephalopathy and seizures. The phenotype of SCN1A seizure disorders can vary even within the same family.</Attribute>
                <XRef ID="NBK1318" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301494</ID>
                <ID Source="BookShelf">NBK1318</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="Orphanet, 2008">
                <URL>https://www.orpha.net/data/patho/Pro/en/Emergency_Dravet.pdf</URL>
                <CitationText>Orphanet, Dravet syndrome, 2008</CitationText>
              </Citation>
              <Citation Type="general" Abbrev="EFNS, 2010">
                <ID Source="PubMed">20298421</ID>
              </Citation>
              <Citation Type="Suggested Reading">
                <ID Source="PubMed">28880996</ID>
              </Citation>
              <XRef ID="33069" DB="Orphanet" />
              <XRef ID="C0751122" DB="MedGen" />
              <XRef ID="MONDO:0100135" DB="MONDO" />
              <XRef Type="MIM" ID="607208" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1766" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4140" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Dravet syndrome</ElementValue>
                <XRef ID="MONDO:0100135" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Severe myoclonic epilepsy in infancy</ElementValue>
                <XRef ID="219513" DB="GeneTests" />
                <XRef ID="Dravet+Syndrome/2332" DB="Genetic Alliance" />
                <XRef ID="230437002" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Epileptic encephalopathy, early infantile, 6 (Dravet syndrome)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 6A</ElementValue>
                <XRef Type="MIM" ID="607208" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Epilepsy, Myoclonic, Infantile, Severe</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">ICE-GTC</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">DRVT</ElementValue>
                <XRef Type="MIM" ID="607208" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">SMEI</ElementValue>
                <XRef Type="MIM" ID="607208" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">SME</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">DEE6A</ElementValue>
                <XRef Type="MIM" ID="607208" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">EIEE6</ElementValue>
                <XRef Type="MIM" ID="607208" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">SCN1A seizure disorders encompass a spectrum that ranges from simple febrile seizures and generalized epilepsy with febrile seizures plus (GEFS+) at the mild end to Dravet syndrome and intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC) at the severe end. Phenotypes with intractable seizures including Dravet syndrome are often associated with cognitive decline. Less commonly observed phenotypes include myoclonic astatic epilepsy (MAE), Lennox-Gastaut syndrome, infantile spasms, epilepsy with focal seizures, and vaccine-related encephalopathy and seizures. The phenotype of SCN1A seizure disorders can vary even within the same family.</Attribute>
                <XRef ID="NBK1318" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301494</ID>
                <ID Source="BookShelf">NBK1318</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="Orphanet, 2008">
                <URL>https://www.orpha.net/data/patho/Pro/en/Emergency_Dravet.pdf</URL>
                <CitationText>Orphanet, Dravet syndrome, 2008</CitationText>
              </Citation>
              <Citation Type="general" Abbrev="EFNS, 2010">
                <ID Source="PubMed">20298421</ID>
              </Citation>
              <Citation Type="Suggested Reading">
                <ID Source="PubMed">28880996</ID>
              </Citation>
              <XRef ID="33069" DB="Orphanet" />
              <XRef ID="C0751122" DB="MedGen" />
              <XRef ID="MONDO:0100135" DB="MONDO" />
              <XRef Type="MIM" ID="607208" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2828722" SubmissionDate="2020-09-15" DateLastUpdated="2020-09-18" DateCreated="2020-09-18">
        <ClinVarSubmissionID localKey="SUB8141552" submittedAssembly="hg19" title="SUB8141552" />
        <ClinVarAccession Accession="SCV001432294" DateUpdated="2020-09-18" DateCreated="2020-09-18" Type="SCV" Version="1" SubmitterName="Diagnostics Services (NGS), CSIR - Centre For Cellular And Molecular Biology" OrgID="507246" OrganizationCategory="other" OrgAbbreviation="AIC-CCMB" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-06-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.1133delT variant is not present in publicly available databases like 1000 Genomes, Exome Variant Server (EVS), Exome Aggregation Consortium (ExAC), Genome Aggregation Database (gnomAD) and dbSNP. The variant is not present in our in-house exome database. The variant was earlier not reported to ClinVar, OMIM and Human Genome Mutation Database (HGMD) in any affected individuals. However a missense variant was reported earlier to HGMD (ID:CM096127) in the same position in similarly affected individuals [Depienne et al., J Med Genet 2009]. In-silico pathogenicity prediction programs like MutationTaster2, CADD etc. predicted this variant to be likely deleterious. The variant causes a frameshift at 378th amino acid position that creates stop codon at 379thamino acid position of the altered transcript. This may either cause a nonsense mediated decay of the mRNA resulting in no protein or a truncated protein due to premature stop codon. The variant meets the criteria of ACMG guidelines to be classified as 'Pathogenic'.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation Type="general">
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <GeographicOrigin>India</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">0</Age>
              <Age Type="maximum" age_unit="years">9</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <NamePlatform>NovaSeq</NamePlatform>
              <TypePlatform>Next-generation exome sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SCN1A">
              <Name>sodium voltage-gated channel alpha subunit 1</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_006920.6:exon 8</GeneLocation>
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_006920.6:c.1133delT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="604403" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="607208" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8141552</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3427477" SubmissionDate="2021-07-01" DateLastUpdated="2021-07-07" DateCreated="2021-07-07">
        <ClinVarSubmissionID localKey="SUB9929925" submittedAssembly="GRCh37" title="SUB9929925" />
        <ClinVarAccession Accession="SCV001739368" DateUpdated="2021-07-07" DateCreated="2021-07-07" Type="SCV" Version="1" SubmitterName="Lifecell International Pvt. Ltd" OrgID="507720" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>A heterozygous one-base deletion in exon 11 of the SCN1A gene (c.1133delT) that results in a frameshift and premature truncation of the protein 2 amino acids downstream to codon 378 (p.Leu378GlnfsTer2) was detected. This frameshift variant is not reported in both the 1000 genomes and gnomAD databases. The gene has a low rate of benign loss of function variants as indicated by a high LoF variants Z-Score of 7.90. The variant is a loss of function variant in the gene, which is intolerant of Loss of Function variants, as indicated by the presence of existing pathogenic loss of function variant NP_001159435.1:p.M1I and 443 others. There are 341 downstream pathogenic loss of function variants, with the furthest variant being 1548 residues downstream of the variant. Based on the above evidence this variant has been classified as Likely pathogenic according to the ACMG guidelines.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation Type="general">
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Ethnicity>Asian</Ethnicity>
              <GeographicOrigin>India</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <NamePlatform>Illumina</NamePlatform>
              <TypePlatform>Next-generation exome sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SCN1A">
              <Name>sodium voltage-gated channel alpha subunit 1</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_001165963.4:exon 11</GeneLocation>
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001165963.4:c.1133delT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="607208" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB9929925</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2828722" TraitType="Disease" MappingType="XRef" MappingValue="607208" MappingRef="OMIM">
        <MedGen CUI="C0751122" Name="Severe myoclonic epilepsy in infancy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2828722" TraitType="Disease" MappingType="XRef" MappingValue="604403" MappingRef="OMIM">
        <MedGen CUI="C1858673" Name="Generalized epilepsy with febrile seizures plus, type 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3427477" TraitType="Disease" MappingType="XRef" MappingValue="607208" MappingRef="OMIM">
        <MedGen CUI="C0751122" Name="Severe myoclonic epilepsy in infancy" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>